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Because of unpredictable corneal changes, evisceration and implantation of a silicone prosthesis does not always lead to a satisfying
cosmetic result. This paper describes the use of an intraocular silicone prosthesis in combination with an extraocular glass
prosthesis and shows a followup of two and a half years in a nonexperimental study. An intraocular silicone prosthesis was
implanted after evisceration of the left eye in a five-month-old Bernese mountain dog. A glass prosthesis was fitted four weeks
after evisceration. Two and a half years after the operation, the dog is in good health and free of medication. No short-term or
long-term complications were seen. The owners do not have trouble with handling the glass prosthesis. The combination of both
prostheses shows a perfect solution to retrieve a normal looking and moving eye after evisceration.
1. Introduction
In both human and veterinary ophthalmology several surgi-
cal options are described to treat an end-stage glaucomatous
eye that does not respond to medical therapy.
The easiest and fastest procedure is enucleation of the
eye. Evisceration and implantation of a silicone prosthesis is
an alternative which gives a better cosmetic result [1–6].
A disadvantage of evisceration and silicone implantation
in dogs is the neovascularization of the cornea immediately
after evisceration. One to twomonths after the operation, the
cornea will be completely vascularized [2, 4, 6, 7]. Parallel
to this process, the cornea becomes fibrotic and sometimes
also pigmented [6]. The extent of blood vessel regression
and the degree of pigmentation and/or opacification varies
between canine eyes. Opacification can lead to unsatisfying
cosmetic results [4, 7]. In a questionnaire for dog owners of
eviscerated patients, 62% of the owners were very content
with the result. Less satisfaction was caused by dense fibrosis
of the cornea [5]. Still, all owners were happy to have
chosen evisceration instead of enucleation. To improve the
cosmetic appearance, in human medicine evisceration is
always combined with an extraocular prosthesis (scleral
shell or “artificial eye”) [8–10]. An extraocular prosthesis
combined with an intraocular prosthesis shows a better
motility than an extraocular prosthesis alone [9, 10]. Table 1
gives an overview of selected options to restore anatomical
structure after exenteration, enucleation, or evisceration.
Figure 1 shows the anatomic relationship of the two prosthe-
ses.
Transscleral cyclophotocoagulation with diode laser or
cryotherapy in combination with an Ahmed gonioimplan-
tation in dogs with primary glaucoma has a success rate of
approximately 76%, and most of the patients still need long-
term medication [12, 13]. Therefore, this method is reserved
for acute glaucomatous eyes, which are still visible or are
believed to have a change to regain vision.
Ciliary body ablation by intravitreal gentamicin injection
for the treatment of end-stage glaucoma is thought to
correlate with the development of malignant intraocular
tumours [14].
This paper shows a followup of two and a half years of a
dog with an intraocular silicone prosthesis combined with an
extraocular glass prosthesis after evisceration.
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Table 1: Overview of selected options to restore anatomical structure after exenteration, enucleation, or evisceration [8, 10, 11]. Depending
on the procedure and the selected prosthesis, a second prosthesis or an “artificial eye” can be placed between the first prosthesis and the
eyelids. Porous implants like hydroxyapatite can be combined with a coupling or peg system, to give the second implant better motility
[8, 10].
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Figure 1: Anatomical position of diﬀerent prostheses. 1: intraoc-
ular prosthesis introduced within the empty tunica fibrosa after
evisceration. 2: second extraocular prosthesis or “artificial eye,”
lying between the conjunctiva (third eyelid in animals) and eyelids.
Brown: eyelid skin, pink: conjunctiva, and yellow: tunica fibrosa.
2. Case Report
A three-month-old, male Bernese mountain dog was pre-
sented to a private veterinarian after a cat claw injury in
his left eye. Ophthalmic examination, including fluorescein
staining, Seidel Test, slit lamp biomicroscopy and B-mode
ultrasound, led to the diagnosis of corneal perforation with-
out injury of the lens. Under general anesthesia, the corneal
wound was cleaned and afterwards closed with simple
interrupted sutures (Vicryl 8/0, Ethicon, Johnson & Johnson,
Norderstedt, Germany). An additional nictitating membrane
flap was performed to protect the corneal wound. Postoper-
ative treatment included topical treatment with neomycin,
gramicidin, and polymyxin B eye drops TID (Polyspectran,
Alcon, Freiburg, Germany) and atropine eye drops SID
(Atropine-POS 1%, Ursapharm, Saarbru¨cken, Germany)
and systemic treatment with amoxycillin-clavulanic acid
12.5mg/kg BID (Clavaseptin, Ve´toquinol, Ravensburg, Ger-
many) for two weeks and carprofen 4mg/kg SID (Rimadyl,
Pfizer, Karlsruhe, Germany) for six weeks.
After six weeks, the eye became blind and the dog
was referred. Ophthalmic examination of the blind eye
revealed secondary glaucoma with an intraocular pressure
of 29mmHg measured by rebound tonometry (TonoVet,
Acrivet-Veterinary Division, Hennigsdorf, Germany). Top-
ical treatment including carbonic anhydrase-inhibitor and
β-blocker eye drops QID (dorzolamide 2% and timolol
0.5%, Cosopt, Merck Sharp & Dohme-Chibret, Clermont-
Ferrand, France) and prostaglandin-analog eye drops BID
(Travoprost 40 μg/mL, Travatan, Alcon, Hemel Hempstead,
United Kingdom) was initiated, but the intraocular pressure
could not be controlled below 20mmHg to prevent further
damage. Seven weeks after the injury, the blind eye became
buphthalmic (Figure 2). The owners elected to eviscerate the
eye and chose an extraocular prosthesis to be installed.
2.1. Surgery Part I: Intraocular Prosthesis. The dog underwent
general anesthesia. The left eye was cleaned in a routine
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Figure 2: Four-and-a-half-month-old Bernese mountain dog with
end-stage, glaucomatous left eye seven weeks after cat claw injury.
Figure 3: Perilimbal perforating scleral incision as preparation for
implantation of intraocular silicone prosthesis.
manner for eye surgery. A Barraquer eyelid speculum was
placed to open the eyelids. The conjunctiva was prepared
for a 360◦ flap by a complete perilimbal incision with a
Stevenson’s scissor. The cornea was excised by a 360◦ scleral
incision with a Beaver blade nr. 65 and Stevenson’s scissor
1mm behind the limbus (Figure 3).
The content of the globe was removed with a lens loop,
leaving an empty scleral shell. An 18mm silicone prosthesis
(Acrivet-Veterinary Division, Hennigsdorf, Germany) (size
of the healthy eye, measured as the distance between the
posterior surface of the cornea and the anterior surface
of the sclerawith B-mode ultrasound) was placed into
the scleral shell with a Carter sphere introducer (Acrivet-
Veterinary Division, Hennigsdorf, Germany). The sclera
was closed above the prosthesis with interrupted horizontal
mattress sutures (Vicryl 6/0, Ethicon, Johnson & Johnson,
Norderstedt, Germany) (Figure 4).
The 360◦ limbal-based conjunctival flap was closed above
the sclera in a simple continuous pattern by the use of the
Vicryl 6/0 (Figure 5).
A temporary tarsorrhaphy with the use of a monofila-
ment suture material (Dafilon 4/0, Braun Aesculap, Tuttlin-
gen, Germany) was performed to protect the empty fornix
(Figure 6).
Figure 4: Closure of the sclera above the intraocular silicone
prosthesis.
Figure 5: Closure of the conjunctiva above the sclera.
The sclera and conjunctiva healed within two weeks, and
after which the tarsorrhaphy was released.
2.2. Surgery Part II: Extraocular Prosthesis. Three weeks after
the surgery, an extraocular prosthesis of glass was prepared
by an ocularist (Figure 7).
The prosthesis was placed into the fornix, above the
conjunctiva, sclera, and intraocular prosthesis (Figure 1).
The extraocular prosthesis was kept in place by its shape,
the third eyelid and the eyelids resting over the border of the
prosthesis.
2.3. Postoperative Care. Postoperative treatment included
systemic treatment with amoxycillin-clavulanic acid
12.5mg/kg BID (Clavaseptin, Ve´toquinol, Ravensburg,
Germany) and metamizol 20mg/kg TID (Novaminsulfon,
Ratiopharm, Ulm, Germany) for five days. No topical
treatment was applied. The wound was examined one day,
one week, and two weeks after surgery. No further systemic
or local medication was indicated.
2.4. Prosthesis Handling. The glass prosthesis has to be
taken out every evening. The prosthesis is placed overnight
in a generally available lens cleaner (for example Boston
Simplus all in one, Bausch & Lomb, Berlin, Germany). In
the morning, the conjunctival sack is flushed with a generally
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Figure 6: Temporary tarsorrhaphy to protect the empty fornix.
Figure 7: Artificial glass eye (extraocular prosthesis).
available eye cleaner (e.g., Albrecht, Aulendorf, Germany),
and the prosthesis is placed back into the fornix.
2.5. Followup. Pictures were taken two months, one and a
half year, and two and a half years after surgery (Figures 8, 9,
and 10).
The extraocular prosthesis was replaced by the same
ocularist for a new prosthesis after one year and after two
and a half years. By experience, the ocularist was able to fit
the last prosthesis in such a manner that less white of the
prosthesis is seen. The only (long-term) complication is a
little intermittent serous secretion. There is no history of a
bacterial infection or insuﬃcient tear production. Schirmer’s
tear test readings were always above 15mm per minute. The
dog is happy, does not need any medication and behaves and
looks like a dog with two normal eyes. The dog does not
show any discomfort with the intraocular and extraocular
prosthesis.
The owners are very satisfied with the cosmetic result and
do not feel inconvenienced by the handling of the extraocular
prosthesis. Given the same circumstances, they would make
the same decision again.
3. Discussion
3.1. Evisceration versus Enucleation. In human ophthalmol-
ogy, the main advantage of evisceration over enucleation
is that evisceration is described as the easier procedure
with less orbital manipulation, hemorrhage, and reduced
postoperative swelling, pain, and associated trauma [8]. In
human ophthalmology eviscerations are also associated with
fewer complications than enucleation due to less periocular
Figure 8: Six-and-a-half-month-old Bernese mountain dog with
intraocular and extraocular prosthesis two months after surgery.
Figure 9: Two-year-old Bernese mountain dog one and a half year
after surgery.
damage caused during evisceration [15, 16]. Postoperatively
the globe still moves normally, because during evisceration
extraocular muscles and their attachments are not disturbed
[8]. Diﬀerent studies in dogs have shown that evisceration
and implantation of a silicone prosthesis is easy to learn,
easy to practice and shows a very low complication rate
in well-selected cases [5, 6]. In dogs, postoperative pain
after evisceration is comparable with postoperative pain after
enucleation [5]. Postoperative local therapy is needed for
two to three weeks after evisceration, and therefore, the
postoperative care is more intensive as after enucleation, but
this was not inconvenient to owners and dogs [5].
3.2. Stimulating Appropriate Orbital Growth in Infants.
Kennedy [17] describes that facial asymmetry and cosmetic
deformity can occur following enucleation. Some studies
in human ophthalmology describe that enucleation of one
eye in infancy or childhood accompanied by insertion of
an implant does not cause a cosmetically significant orbital
variation [18, 19]. An experimental study in young cats
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Figure 10: Three-year-old Bernese mountain dog two and a half
years after surgery.
testing tissue expanders in the anophthalmic orbit after
enucleation showed that insuﬃcient tissue expanding led
to asymmetric skull development [20]. In the presented
case a tissue expander implant was not available at the
time of surgery. The combination of an intraocular silicon
prosthesis with an extraocular glass prosthesis did not lead
to visible facial asymmetry. Additional radiographic studies
to measure the volume of both orbitae are lacking due to
clinical irrelevance in the presented patient.
3.3. Operation Technique. In this case the evisceration was
combined with a full-thickness keratectomy, because the eye
was so buphthalmic. Additionally, in human ophthalmology
excision of the cornea is described for those patients who
may still have corneal sensation or corneal pain. The removal
of the cornea allows the sclera edges to be united, which
provides a secure wound closure [8]. As the owners of the
dog already decided preoperatively for a second extraorbital
prosthesis, it was attempted to establish the best basis for
this second prosthesis. Without the cornea, no cornea-
related complications, such as a deep (nonhealing) ulcer, can
develop.
Due to the preoperative buphthalmic eye, the silicone
implant, which was the size of the other normal eye, could be
introduced, and the sclera wound could be opposed without
tension releasing incisions or posterior radial sclerotomies,
which may be used in human ophthalmology [8, 9]. A
buphthalmic globe contracts around the implant within one
to twomonths to conform to the size of the implanted sphere
[2].
3.4. Implant Material. In dogs, implantation of silicone
prosthesis after evisceration has been used already for many
years [1–6]. In more recent studies with well-selected cases,
no extrusion of the prosthesis was seen and no secondary
enucleation was needed [2, 5, 6].
The first extraocular prostheses for humans were made
of glass, mainly produced in Germany. During World
War II, an increased demand for glass eyes and limited
export from Germany led to the development of acrylic
prostheses [11]. Glass causes no allergic reactions [10]. The
manufacturing of the prosthesis takes approximately one
hour. The measurement and placement in the patient can be
done during one consultation [10]. Disadvantages of glass
are the gradual break down of the smooth surface over
time and the need to renew the prosthesis every one or
two years [21]. Furthermore, glass can become very cold in
windy or cold weather. This can cause pain to the eyelids
in contact with the prosthesis [10]. Acrylic prostheses have
a very large mechanically resistance and therefore last five
to ten years. After manufacturing, the prosthesis can be
molded several times. The measurement and placement in
the patient takes normally two to three visits. Theoretically,
acrylics can cause allergic reactions. To maintain the surface
smooth and clean, the prosthesis has to be polished once a
year [21]. In Germany, ocularists prefer to use glass whereas,
for example, in the Netherlands the ocularists prefer to use
acrylic prostheses [22]. In the presented case, the ocularist
preferred to use glass for the extraocular prosthesis.
In an eviscerated eye without keratectomy in which a
fibrotic cornea develops a tinted bandage lens can be tried to
camouflage the white appearance. Care must be taken with
those eyes that develop a lower tear production.
3.5. Prosthesis Motility. The motility of an intraocular pros-
thesis together with the extraocular prosthesis can be further
increased by addressing a motility coupling system, like a
peg, between the two prostheses [10, 23]. This improvement
is reported to be relatively small in eﬀect and neutralized by
the need of a second anesthesia or sedation and increased
rate of complications like persistent discharge, pain, and peg
extrusion [9, 10, 24, 25].
3.6. Postoperative Complications. Diﬀerent studies show that
10% of the eviscerated canine eyes developed a keratocon-
junctivitis sicca (KCS) [4, 5, 26], but within this presented
case no signs of KCS were seen.
This paper shows that the combination of both prosthe-
ses oﬀers a good treatment option with very good cosmetic
results, with no discomfort for the dog and no need for
additional medication.
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